Prevention and early detection is critical for reducing the population cancer burden. Two approaches have been used: Population approaches change social norms (e.g., smoking bans) or impose incentives (e.g., cigarette taxes); high-risk strategies intervene upon individuals with elevated cancer risk (e.g., smoking cessation). Knowledge about carcinogenesis mechanisms, extreme exposures, and inherited susceptibility provides opportunities to develop precision prevention and early-detection (PPED) strategies. PPED aims to understand the basis of risk, identify groups that optimally benefit from interventions, characterize heterogeneity in intervention responses, optimize intervention timing, and minimize toxicities. We propose a framework arou...
Individuals who inherit a high penetrance cancer susceptibility gene represent a population in which...
The constant increase of cancer incidence and the huge costs of new treatments make cancer preventio...
The poor outcomes for cancers diagnosed at an advanced stage have been the driver behind research in...
Prevention and early detection is critical for reducing the population cancer burden. Two approaches...
Approaches to reduce the global burden of cancer include two major strategies: screening and early d...
We present a model to plan a rational strategy for cancer prevention that has two main functions--as...
We present a model to plan a rational strategy for cancer prevention that has two main functions--as...
The rapidly increasing incidence and mortality of cancer calls for a focused effort to increase the ...
Epidemiological studies of cancer is the corner stone of cancer control plans and necessary for sett...
Current treatments of cancer are imperfect and entail risks. For many malignancies, the best “treatm...
Survival improves when cancer is detected early. However, ~50% of cancers are at an advanced stage w...
Cancer imposes a heavy societal burden worldwide, in terms of both epidemiology and costs. The intro...
Annually, there are 1.6 million new cases of cancer and nearly 600,000 cancer deaths in the United S...
Colorectal cancer is a major cause of cancer-related mortality. Most colorectal cancers arise in pre...
The poor outcomes for cancers diagnosed at an advanced stage have been the driver behind research in...
Individuals who inherit a high penetrance cancer susceptibility gene represent a population in which...
The constant increase of cancer incidence and the huge costs of new treatments make cancer preventio...
The poor outcomes for cancers diagnosed at an advanced stage have been the driver behind research in...
Prevention and early detection is critical for reducing the population cancer burden. Two approaches...
Approaches to reduce the global burden of cancer include two major strategies: screening and early d...
We present a model to plan a rational strategy for cancer prevention that has two main functions--as...
We present a model to plan a rational strategy for cancer prevention that has two main functions--as...
The rapidly increasing incidence and mortality of cancer calls for a focused effort to increase the ...
Epidemiological studies of cancer is the corner stone of cancer control plans and necessary for sett...
Current treatments of cancer are imperfect and entail risks. For many malignancies, the best “treatm...
Survival improves when cancer is detected early. However, ~50% of cancers are at an advanced stage w...
Cancer imposes a heavy societal burden worldwide, in terms of both epidemiology and costs. The intro...
Annually, there are 1.6 million new cases of cancer and nearly 600,000 cancer deaths in the United S...
Colorectal cancer is a major cause of cancer-related mortality. Most colorectal cancers arise in pre...
The poor outcomes for cancers diagnosed at an advanced stage have been the driver behind research in...
Individuals who inherit a high penetrance cancer susceptibility gene represent a population in which...
The constant increase of cancer incidence and the huge costs of new treatments make cancer preventio...
The poor outcomes for cancers diagnosed at an advanced stage have been the driver behind research in...